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PREFACE 
 
The data from this study were collected between 1997 and 1999 and several 
changes have occurred locally since that time.  For several years and at the time of 
the study, issues relating to drug misuse fell under the authority of the Northern 
Ireland Office.  Since 2000, the Department of Health, Social Services and Public 
Safety (DHSSPS) has assumed much of this responsibility, and symbolically this 
change places greater emphasis on the health aspects, as opposed to the criminality 
of drug misuse.   Under the direction of DHSSPS the first pharmacy-based needle 
exchange programmes were implemented in 2001.  Evaluation data from these 
programmes will be viewed with great interest and will further our understanding of 
accessibility and utilisation of the schemes.  The DHSSPS also established the Drug 
Information and Research Unit, where staff are engaged in the management of data 
and the dissemination of information relating to drug misuse.  In particular, the Unit 
has primary responsibility for the management of the recently developed, Northern 
Ireland Drugs Misuse Database. Another important change has been the creation of 
the post, Northern Ireland Drug Strategy Co-ordinator, held by Ms. Jo Daykin.  Prior 
to that appointment, she was extensively involved in work relating to drug treatment 
and that experience may influence the direction of drug policy in Northern Ireland.  
Additional research, conducted since the data for the present study were collected, 
will contribute to our knowledge of injection drug use in Northern Ireland.  A 
qualitative study of heroin users in Ballymena has commenced (Kathryn Higgins, 
Centre for Child Care Research, Queen’s University, Belfast), and the local Public 
Health Laboratory Service plans to examine seroprevalence for HIV and other 
infectious disease among injecting drug users seeking drug treatment.  Additionally, 
the DHSSPS has provided funds for research that will 1) provide estimates of the 
number of heroin users in Northern Ireland, and 2) examine the need for substitute 
prescribing in Northern Ireland.   Results from these studies will further our 
understanding of heroin and injecting drug use in Northern Ireland.        
 
 
 
 
  
 
Note: 
 
An article on risk behaviours, drawn from this study, will be published in a 
forthcoming issue (2001) of the journal, Substance Use and Misuse.    
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 5 
INTRODUCTION 
 
Self-report studies based on samples of youth or young adults in Northern Ireland 
generally find lifetime prevalence rates for heroin use to be quite low, i.e., two 
percent or less (Craig, 1996; Health Promotion Agency for Northern Ireland, 1995; 
Miller and Plant, 1996; Northern Health and Social Services Board, 1996).  Surveys 
of adults in Northern Ireland also show low rates of heroin use (Northern Ireland 
Office, 1998).  These lifetime prevalence rates are fairly consistent with figures 
reported in Britain (e.g., Ramsay and Spiller, 1997) and in the United States (National 
Institute on Drug Abuse, 1996).   
 
Official health indicators of heroin use in Northern Ireland include notification data 
and information pertaining to Hepatitis B, Hepatitis C, and Human Immunodeficiency 
Virus (HIV).  Physicians are required to notify the Chief Medical Officer of the 
Northern Ireland Department of Health and Social Services when they attend a 
patient whom they consider to be or have reasonable grounds to suspect that s/he is 
addicted to cocaine or one of 13 opiates (heroin included).  Although the overall 
number of notifications for these drugs has increased in Northern Ireland since 1995, 
the inadequacies of notification data have been documented (Hay and McKeganey, 
1996).  For instance, notification data are affected by the subjective decisions (Strang 
and Shah, 1985) and by regulatory compliance among physicians (Mott, 1994).  Data 
reported by the Public Health Laboratory Service in Northern Ireland show low rates 
of Hepatitis B and C, and HIV transmitted through injecting drug use.   These data, 
however, are limited in that they only include cases in which persons have been 
tested for disease.  Additionally, individuals who test positive in other countries for 
these diseases, but who live currently in Northern Ireland, may not be included in the 
data.   
 
With respect to other drug indicators, data indicate that seizures of heroin by police 
have increased since 1995.   Drug seizures, however, are often a poor indicator of 
drug use (South, 1995), and may more accurately reflect a change in the reallocation 
of police resources (Hollywood, 1997).       
 
Although self-report studies and official indicators of drug use can provide useful 
information about various phenomena, they reveal little about the context of drug 
use, or the behaviours, lifestyles and experiences of drug users.  Qualitative research 
can contribute greatly to our understanding of illicit drug use and can also provide 
insight into the development and implementation of effective interventions (Fountain 
and Griffiths, 1999).  The present study utilised a qualitative approach whereby in-
depth interviews were conducted with persons who had injected or chased heroin in 
Northern Ireland.  The study represents one of the first research investigations into 
heroin use in Northern Ireland.1 In the absence of needle exchange and methadone 
maintenance it is important to learn how heroin users manage their drug careers and 
the findings presented herein shed some light with regard to this issue.    
 
The purpose of the study was to examine patterns of drug taking, health issues (e.g., 
Hepatitis C), risk behaviours associated with injection practices (e.g., sharing 
injection equipment), experiences with drug treatment and related issues.  The report 
includes a description of the methodology, selected findings and recommendations.  
 
                                                           
1 Previous studies that addressed heroin or injection drug use in Northern Ireland 
include O’Neill (n.d.) and Carney et al. (n.d.).   
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METHODOLOGY 
 
Sample and Recruitment 
 
The sample included 43 current or former users of heroin who had used heroin 
(injected or chased) in Northern Ireland.  Given the exploratory nature of the study 
and the limited research into heroin use in the region, ‘any use of heroin in Northern 
Ireland’ was the only criterion for study participation.2 
 
The study commenced in September 1997, although the majority of interviews were 
conducted in 1998 and 1999.  Several strategies were undertaken in order to recruit 
potential candidates for the study.  A description of the study was prepared and 
distributed to various contact persons after initial correspondence was conducted by 
telephone.  Persons with whom the researcher made contact included selected 
community workers (e.g., persons working with youth, within large estates), general 
practitioners (GPs), treatment providers (statutory and voluntary) and other agencies 
that provided counselling in the areas of drugs or HIV/AIDS.  Multiple contacts were 
made with treatment and other agency ‘gatekeepers’ throughout the study period, 
reminding them of the need for study participants.   Copies of the study description 
also were placed near chemist venues, in selected GP offices and related sites and 
in news and entertainment sources.  Additionally, a ‘snowball sampling’ strategy was 
used whereby persons who completed an interview were asked to refer other 
persons (e.g., friends, acquaintances, partners) who had used heroin.  In all, 22 
respondents were recruited through ‘snowball sampling.’ Other sources of referral 
included: persons that had knowledge of or informal access to the local drug scene 
(N=9), GPs and their offices (N=3), interviewers employed with a research project on 
Ecstasy use (N=3), one community addiction service (N=2), adverts posted adjacent 
to chemist shops (N=2), a local entertainment guide (N=1)3, and an unknown source 
of referral.4   
 
Demographic Characteristics of the Sample 
 
Demographic data of the sample were as follows:  Most respondents were male 
(N=36) and respondents’ ages ranged from 18 to 48 (mean=30 years; median=29).  
Social class was defined by respondents.  Thirteen persons were uncomfortable with 
this question; of the remainder, one identified herself as being ‘poor,’ 11 identified 
themselves as working class, four reported being ‘between’ working and middle 
class, ten were middle class, one reported being ‘between’ middle and upper class 
and two identified themselves as being from upper income backgrounds.  In 
response to the ‘social class’ question, one respondent reported that he was 
                                                           
2 Interviews were conducted with two persons who were born and raised in Northern 
Ireland but had never used heroin here.  One had a lengthy history of heroin injection 
in two other countries, and had returned to Northern Ireland approximately two years 
before the interview date.  The second respondent had chased heroin on a number 
of occasions but had never injected.  He had returned to Northern Ireland a few 
months before the interview.  The decision to interview these respondents despite 
their never having used heroin in Northern Ireland, was based primarily on the fact 
that both males believed that it was necessary for them to leave the heroin scene in 
which they were familiar so that they might abstain from heroin, hence their return to 
Northern Ireland.      
3 An advertisement that described the study appeared for a two-week period in one 
issue of ‘That’s Entertainment’.   
4 One respondent was so paranoid about protecting his anonymity, I purposely 
avoided asking him where or from whom he had learned about the study. 
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homeless.  Twenty-six percent (N=11) of the respondents were employed in part- or 
full-time work at the time of the interview, 7% were students and 61% of the sample 
were unemployed (information was missing for three respondents).   
 
Comparing these demographic data with findings reported from other studies is 
problematic in that studies differ greatly with respect to recruitment sources (e.g., 
treatment versus street sources), sampling strategies, and method and year of data 
collection.  Nevertheless, the gender and age distribution of the sample are 
consistent with findings reported elsewhere.  For example, a multi-city study of 
injecting drug users and HIV conducted by the World Health Organization (WHO, 
1994) found that IDUs tend to be largely male (e.g., Berlin=55%; Bangkok=95%) and 
between 20 and 34 years of age.  A multi-site National AIDS Demonstration 
Research Program, based on interviews with approximately 60,000 drug injectors 
and their sex partners in the United States, found that males comprised 75% of the 
38,561 heroin users (Inciardi et al., 1998).  Similarly, male IDUs comprised 72% of 
the sample in an Edinburgh survey conducted over a three year period (Peters, 
Davies and Richardson, 1998).  The median age of IDUs in the Edinburgh study was 
27 years.  Prevalence estimates drawn from a capture-recapture study in Dublin 
found that of several gender/age groups, males, aged 15 to 24 included more opiate 
users than other gender/age combinations (Comiskey, 2000).  Because Comiskey’s 
study focused on prevalence, means and medians, were not reported.        
 
The present study includes a smaller proportion of unemployed persons (N=61%) 
compared to studies conducted elsewhere.  For example, Maher and Dixon (1999) 
conducted an ethnographic study of 143 heroin users in Australia in which 84% were 
unemployed at the time of the interview.  Similarly, a survey conducted on the Wirral 
in 1985-1986 found that 83% of the opiate users were unemployed (Parker et al., 
1988).  
 
A majority of respondents (N=35) lived in County Antrim at the time of the interview, 
32 of whom resided in Belfast.  Seven respondents lived in various parts of County 
Down and one respondent resided in the south of Ireland but visited his partner in 
Northern Ireland on a regular basis.   Although some of the respondents were born 
and raised in areas outside Belfast, most resided in Belfast at the time of the 
interview, thus, the sample is based largely on persons who resided in an urban 
setting during some or most of the heroin career.  Their experiences may differ 
substantially from heroin users who live elsewhere in Northern Ireland.  For example, 
a study conducted in Australia found that rural and urban injecting drug users differed 
in terms of their injecting practices, needle sharing, and prevalence and incidence of 
Hepatitis C (Aitken, Brough and Crofts, 1999).   Haw and Higgins (1998) found fewer 
differences between rural and urban injectors in Scotland although urban injecting 
drug users (IDUs) had higher rates of HIV and were more likely to share injection 
equipment with persons outside their immediate social network. 
 
Interview Guide  
 
The interview guide consisted of a number of items relating to patterns of heroin use 
(e.g., frequency, dosage, age at onset, method of administration), risk behaviours 
associated with injection practices, descriptions of first, last and heaviest use of 
heroin, treatment experiences (including ‘self-help’ strategies), interactions with 
medical staff regarding heroin use, and related lifestyle and attitudinal issues.  
Historical information on other drug use as well as demographic data were collected 
at the conclusion of the interview.  Interviews were conducted in various settings, 
including a university office (N=29), respondents’ homes (N=7), treatment sites 
(N=1), community drop-in centres (N=3) and public venues (N=3).  Interviews were 
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conducted within a one- to three-hour time frame.  Tape recordings were not used 
with this sample; rather, the researcher took notes during each interview.  This 
decision was based on the assumption that heroin users represent a marginalised 
sub-culture in Northern Ireland, whose behaviour is highly stigmatised.  The 
researcher believed that respondents might be concerned about voice identification 
from taped interviews; field notes removed this threat.  Respondents were assured of 
anonymity and confidentiality and paid £15-20 for their participation in the study.5     
 
 
                                                           
5 Several ethical protocols were followed in the study.  For example, with few 
exceptions, the interview site was determined by the respondent who was provided 
with several options and asked to choose the interview setting in which s/he was 
most comfortable.  Also, respondents were reminded that they could end the 
interview at any time, and without consequence.  Efforts were made to ensure that 
the interview questions did not cause psychological or emotional harm to the 
subjects.    
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FINDINGS   
 
Initiation 
 
Geographic Location and Age 
 
The majority of respondents (i.e., 61%; N=26) initiated heroin use in other countries; 
the remainder initiated in Northern Ireland.  The average age of initiation into heroin 
use was very similar in both groups (persons who first used in Northern Ireland=19 
years; elsewhere=20 years).  Persons who initiated use in Northern Ireland did so an 
average of 4 to 4½ years later (average year = 1990-1991) than persons who 
initiated heroin use elsewhere (average year = 1986).  The data are summarised by 
decade in Table 1: 
 
      Table 1.  Place of Initiation into Heroin Use  
              (raw numbers) 
     
    Northern Ireland      Elsewhere 
 
  Decade 
 
        1970s              ----  4a 
 
        1980s    7            13 
 
        1990s              10   9 
 
 
         Note:  a This figure includes one respondent 
           who initiated heroin use in 1969. 
 
These data indicate that more than half of the respondents who initiated use in 
Northern Ireland did so in the 1990s.  Comparatively, half of the respondents who 
initiated heroin use elsewhere, did so in the 1980s.   The earliest year during which 
initiation occurred in Northern Ireland was 1981 (data not shown in tabular form).  
 
It should also be noted that one may initiate heroin use through chasing in one 
country, but first inject in another.  In fact, five respondents who initiated heroin 
elsewhere, subsequently injected the substance for the first time in Northern Ireland.   
One respondent initiated heroin use through sniffing in Canada, first chased heroin in 
London, but injected first in Northern Ireland.   
 
Reasons for Initiating Heroin Use  
 
Curiosity is an important factor in the decision to initiate heroin use (Stephens and 
McBride, 1976; Waldorf, 1973) and several respondents in the present study 
mentioned curiosity as a motivating reason using heroin initially.  However, this factor 
also has been identified as a reason for trying various drugs (Solowij, Hall and Lee, 
1992; Spruit, 1997).  Parker et al. (1988: 47) suggested that curiosity to use heroin is 
often ‘aroused by the previous use of other drugs.’  A qualitative component of a 
Dublin study of heroin users supported this claim in that use of other drugs ‘was 
already an accepted feature of young people’s lives’ (Coveney et al., 1999: 33).  
Findings from the present study are consistent with these results:       
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‘I was chasing a high.  I had tried everything.  I was curious’ (009, first chased 
heroin at age 18, injected at age 19-20). 
 
‘I’d do this [heroin] and see what it was like.  I had had other drugs in Belfast’ 
(051, initiated in Denmark in 1969). 
 
‘I wanted to be part of it…I’d done everything – glue sniffing – you name it’ 
(010, first injected brown heroin in Northern Ireland, 1983).   
 
The opportunity to use heroin also has been identified as an important factor in 
initiation (Stephens and McBride, 1976).  People generally do not seek heroin for 
initial use; rather, most individuals ‘stumble upon [situations conducive to use] quite 
accidentally’ (Stephens, 1991: 76).  A male respondent in the present study reported 
being with a female friend and a male supplier.  The respondent and the female 
friend had used acid and cannabis but neither had used heroin.  The respondent 
recalled that the female friend had stated, ‘So and so is coming to the house – want 
to try smack?’  The respondent reported that he was ‘dubious, but curious’ and tried 
the drug at that time (007).    
 
Parker et al. (1988) interviewed five persons who reported trying heroin when their 
preferred drug was not available.  The ready availability of heroin contributed, albeit 
passively, to initiation.  In the present study, four respondents reported that they had 
not intended to use heroin but did so after their drug of choice was not available.  
One respondent had hoped to buy amphetamine but his regular supplier could not 
get the substance.  The supplier did have heroin available for sale which the 
respondent then purchased (041).  Another respondent reported being a regular user 
of crack cocaine.  On a day when he could not find crack, a supplier ‘found heroin for 
me’ (002).  Two respondents reported that they had intended to buy cannabis but 
that none was available.  One of these persons indicated that the dealer had 
mentioned the availability of heroin instead (032, snorted heroin initially in Dublin).   
The second reported that his suppliers were injecting when he called to buy 
cannabis.  He snorted the heroin, but did not use it again until the following year 
(074).  
 
Some respondents, however, reported that they had declined to use heroin when 
they first were presented with an opportunity to use.  One male described an event 
that occurred in Northern Ireland in 1993, before he had ever used heroin.  He was 
party to a setting within which two acquaintances were about to inject heroin.  ‘I 
freaked – chickened out – I [literally] ran away [from the scene]’ (009).  Another 
respondent had friends/acquaintances in his company at various times who were 
injecting heroin.  He had injected amphetamine in their company from time to time, 
but he did not use heroin until three years later, when initiation occurred through 
chasing (004).      
 
Friends’ use of heroin also has been identified as a factor that contributes to initiation 
into heroin use (Waldorf, 1973).   Only a few respondents in the present study 
alluded to the importance of friends’ use.  A male respondent’s good friend and 
house mates were chasing regularly and the respondent described them as ‘very 
intelligent’ persons who were graduates of a prestigious university in England, and 
who had ‘everything going for them’ (050, first chased at age 22).  Another reported 
being influenced by her boyfriend, whom she had dated for four months prior to her 
initiation: 
 
 ‘…He had used before and he wanted me to appreciate it’ (003, age 19). 
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Other reasons for initiation were provided as well.  For example, a male reported that 
his drug of choice was amphetamine, a substance that he eventually injected 
because he ‘no longer got the effect from just snorting it.’  (004).  He believed, 
however, that the amphetamine eventually produced some powerful and ‘terrible 
hallucinations.’ He lists this factor as the major reason why he first used heroin, 
chased for two years and then progressed to injection.  Heroin helped ‘to keep myself 
normal.  [When using heroin] I felt normal’ (004). 
 
Route of Administration 
 
Maher and Dixon (1999) found that 52% of the heroin users in their Australian study 
had initiated heroin use through injection.  A substantially lower percentage was 
found in the present study whereby 30% (N=13) of the respondents had initiated 
heroin use through injection.  About one-half (N=21) of the present study’s sample 
had initiated through chasing; 12% (N=5) initiated through snorting/sniffing, and 7% 
(N=3) through smoking (non-chasing).6,7  Persons who had initiated in Northern 
Ireland were just as likely to do so through injection (29%) as were persons who 
initiated elsewhere (32%).     
 
As discussed above, 29 of the 43 respondents had initiated heroin use through 
means other than injection. Of this group, all but four persons subsequently 
progressed to injection.  Further, most respondents injected heroin within one to two 
years of initiation through chasing, smoking or snorting although this time period 
varied from one week to 11 years.    
 
Injection generally is more difficult to master than swallowing, sniffing, snorting or 
smoking a drug, thus, most people must be taught how to inject (and to a lesser 
extent, how to chase).  ‘Teachers’ often play a crucial role in the initiation of others 
into heroin use (Waldorf, 1973).  Indeed, most respondents in the present study 
reported that other IDUs either injected them or showed them how to inject heroin or 
another substance.  ‘Teachers’ were largely male although in four instances, female  
IDUs played the role of teacher for male initiates.  ‘Teachers’ also are important when 
initiation occurs through chasing.  In this setting, ‘teachers’ have been known to heat 
the foil in which the heroin is placed, and hold it, allowing the beginner to inhale the 
vapours (Griffiths, Gossop, and Strang, 1994).             
 
Drug use history and polydrug use 
 
Heroin was the preferred drug of choice for most of the respondents.  Others 
preferred a second drug in addition to heroin.  For example, when asked about their 
‘drug of choice’ three persons listed both heroin and cocaine (014, 042, 074), one 
listed heroin and crack cocaine (075), one listed heroin and amphetamine (080), and 
two listed heroin and Morphine Sulphate Tablets (MSTs) (002, 009).  The remainder 
did not consider heroin to be their drug of choice, preferring cannabis (032, 033, 
034), amphetamine (031), hallucinogens (013), cocaine (072), crack cocaine (005, 
071), and Ecstasy (024).      
                                                           
6 Data were missing for one respondent.   
7 Purity levels represent one factor that can influence the desire to inject rather than 
to chase heroin.  Injecting is the most efficient method to administer low purity heroin.  
Alternatively, chasing high purity heroin can produce significant effects for the user.   
Heroin users have been known to adapt to drug market changes.  For example, as 
heroin becomes less available and purity decreases, injection of the substance may 
increase (Grund et al., 1992). 
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Ninety-eight percent of respondents had consumed cannabis at some stage, and 
35% of the sample (N=15) had used cannabis daily during the six-month period prior 
to the interview.  These figures are similar to those found in a Northern Ireland study 
of Ecstasy users (McElrath and McEvoy, 1999).  Ninety-three percent of the 
respondents in the present study had used hallucinogens (LSD or magic 
mushrooms).  Ninety-eight percent had used amphetamine and 35% had injected the 
substance.  The vast majority (95%) had consumed Ecstasy, and some had injected 
the substance.  One-half of the sample (N=17) had used Ecstasy in the six months 
preceding the interview, but only seven persons had used Ecstasy at least once a 
month during that time period.  Further, about half the sample (N=21) initiated 
Ecstasy use after heroin initiation, a finding that might reflect drug preferences, 
differences in drug markets, or the historical availability of Ecstasy in Northern 
Ireland.  
 
Ninety percent had snorted cocaine, and 63% of the sample had injected cocaine.  
Research in New York City has shown that use of crack cocaine is fairly common 
among heroin users (Brunswick and Titus, 1998).   Indeed, the majority of 
respondents (80%) in the present study had used crack cocaine.  Several persons 
had injected crack cocaine, a finding that reportedly has been increasing in London 
(Hunter et al. 1995).  
 
With the exception of cannabis, most respondents did not use these other drugs on a 
‘regular basis.’ For example, 12 persons had used cocaine (through snorting or 
injecting) during the six-month period prior to the interview, three of whom had used 
the substance once a month or more.  Only two persons reported using crack 
cocaine at least once a month during the six-month period prior to the interview.   
 
Respondents who had tried crack cocaine held mixed opinions of the drug.  Some 
described it in negative terms, e.g., a ‘horrible experience’ (009).  Another stated that 
his use of heroin was ‘manageable,’ despite chasing ½ gram of heroin per day during 
his heaviest period of use.  He reports that his life changed drastically when he 
began using crack cocaine:   
 
‘I hit rock bottom. I stole, lied and manipulated.  With heroin – no – I got far 
worse once I used crack’ (050, age 28).   
 
A female had injected cocaine but preferred crack, and on one occasion she and 
another person consumed several grams of crack cocaine in one night (005).  A male 
respondent reported using crack cocaine nearly everyday for a period of two years 
(046).  He also consumed between one and two grams of heroin during his heaviest 
use of that drug.   
 
Most respondents had at some stage used another drug to ‘substitute’ for heroin 
when that drug was not available.  For example, 92% of the sample had used 
Temazepam, a drug which has been linked with overdose among injectors 
(Hammersley, Cassidy and Oliver, 1995).  Several respondents had injected 
Temazepam, although frequency of use through this method was quite low.  
Respondents’ use of other drugs included:  Diconal, Dihydrocodeine (DFs), 
Morphine, Morphine Sulphate Tablets (MSTs), Palfium, Pethidene, and Temgesic.         
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Patterns of Heroin Use 
 
Current and former users  
 
For this study, ‘current users’ included those respondents who had used heroin within 
the two-month period prior to the interview.  This definition is consistent with that 
used by the World Health Organization (WHO) in its multi-site study of injecting drug 
users (WHO Collaborative Study Group, 1993).  Using this definition, most of the 
respondents (N=25) were categorised as current users of heroin.  About one-third 
(N=14) of the sample were former users, i.e., had purposely abstained from heroin 
for at least two months prior to the interview (range = two months to four years).  The 
remaining number of respondents (N=4) did not fit neatly into these categories.  Two 
respondents, for example, had stopped using heroin about one month prior to the 
interview but were determined that abstinence would be permanent.  A third 
respondent had used heroin one time only and he had never injected.  A fourth 
respondent had chased three times, events which had occurred well before the two-
month cut-off period.  He was fairly certain, however, that he would use heroin again.  
Additionally, some of the ‘former users’ who had abstained from heroin continued to 
use other drugs, such as cannabis, or DFs and diazepam to assist with anxiety and 
other symptoms.  
 
Fluctuations in heroin use  
 
Several respondents indicated that they had experienced periods of daily use of 
heroin, but for various reasons would at times abstain temporarily or use less 
frequently.  A male respondent reported that he had snorted or injected heroin nearly 
everyday from age 21 to 27 (032, age 39).  Since that time, he had ‘dabbled’ a bit but 
had never again used as frequently.  Another respondent had injected ½ to 1 gram of 
heroin per day during a two-year period in her early 20s (048).  She abstained 
altogether for approximately nine years.  During the interview she noted that:   
 
‘I’ve been dabbling [with heroin and MSTs] for three to four months.  I’ve 
injected ½ dozen times in [the last] three to four months’ (048).   
 
Some respondents reported that their ‘heaviest’ use of heroin consisted of using daily 
whenever possible over a period of 28 years (050), once or twice a day for a six-
month period (034), injecting one to two grams per day for several months (044, 
046), and injecting ½ gram of heroin per day and spending £1,000 per month on 
heroin (021).  Others reported using greater amounts.  For example, one male 
respondent reported that he had used approximately 3 ½ grams of heroin per day, 
early on in his heroin career.  He confided this amount to treatment staff but recalled: 
‘No one believed I was using that much but I was’ (041).8  This peak usage was 
followed by a 16-month period when the respondent used on a few occasions only.  
The peak usage coincided with his parent being ill, and the respondent believes that 
this illness triggered his heavy use.  Similarly, another respondent claimed that he 
never used heroin to ‘celebrate’ some event or happy occasion; rather heroin was 
used only when things were going badly (074).         
 
Switching between injecting and chasing 
 
Several respondents noted that they switched from injecting to chasing at times.  
Some did so because they perceived chasing to be ‘more sociable’ (015, 075). A 
                                                           
8 This amount is entirely possible; higher amounts with daily use have been 
documented (Gossop, 1998: 137-138).   
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male respondent had injected heroin, often on a daily basis, over a period of 14-15 
years.  His last injection occurred four months before the interview although he had 
chased on several occasions during that time:  ‘I’m trying to get off it – so I’m 
chasing.’ (014), thus, self-regulation was used in an effort to get clean.  Others 
preferred to inject but at times would chase because ‘I’d no needle on me’ (047).  
Although one person mentioned that he preferred to chase because ‘needles frighten 
me’ (034), no one suggested that they chased because of the risks associated with 
injection.9  
 
Risk Behaviours 
 
The majority of respondents reported great difficulties in obtaining new needles/ 
syringes to be used for injecting heroin and other drugs.  The limited supply of 
needles as well as the cost of purchasing needles, contributed to a number of 
behaviours that pose risk for HIV and other infectious diseases, and contribute to 
other health consequences.    
 
Obtaining needles/syringes 
 
A number of difficulties were reported by respondents who tried to purchase needles 
from chemists in Ballymena, Bangor, and other areas outside Belfast (e.g., 029, 030).   
 
‘One chemist sold out of decency.  Another chemist stopped selling when the 
deaths occurred…[A third chemist required you] to sign your name’ [for 
needles but not for prescription or over-the-counter drugs] (004, male).      
 
The respondent reported that his group would not buy needles from chemists very 
often because ‘too many people, going back too often would spoil it for us.’ (004).   
A respondent who lives in a town/city in County Down reported that he never has 
purchased needles from a chemist there because, ‘They all know my family’ (034). 
 
A male respondent lived in Belfast at the time of the interview and recalled an 
occasion in which he attempted to buy needles from a chemist in Ballymena.  The 
employee had refused the sale and at the time, he was quite ‘sick’ [withdrawal].   
 
‘I asked for a pen and paper and said, “I want your name and [the name of 
this chemist” ‘ (080, age 27).   
 
The employee then provided him with one needle.  On several occasions, this 
respondent had made great attempts to obtain new needles.  He admitted that he 
had stolen needles from hospitals but had also obtained them from Merchant Quay in 
Dublin when he scored in that city.    
 
Although he chases more than he injects, a respondent reported that he has 
purchased needles from dealers in Ballymena because chemists in Ballymena will 
not sell them to him (030).  A few Belfast respondents reported that Belfast users 
have ‘swapped needles for gear [heroin] in Ballymena’ (001).  Indeed when this 
researcher asked a few users how she could recruit other respondents from 
Ballymena, one suggested that she offer new needles/syringes as opposed to money 
as an incentive for study participation. 
                                                           
9 Chasing heroin through inhalation of vapours has its own health risks.  For 
example, studies conducted in Amsterdam (Wolters et al., 1982) and in New York 
City (Wren, 1996) have documented several cases of leukoencephalopathy – a 
neurological disorder – among chasers. 
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Most of the Belfast users reported that chemists had refused to sell needles/syringes 
to them at various times.  For some persons, refusals occurred frequently.   Some 
perceived that a successful purchase depended on the ‘way you looked’ (006), or 
never visiting the same chemist twice (048).  The interview data clearly suggested 
that most respondents had made several attempts to purchase new needles but 
faced with structural barriers, were forced to use various negotiation skills in order to 
obtain.   
 
Multiple injections 
 
Needles are intended to be used one time only.  However, the lack of available 
needles contributed greatly to multiple injections with the same needle.  One 
respondent noted that he often uses the same needle several times per day over a 
period of a few weeks (041).  Another reported: 
 
 I’ve used one needle 14 times over a few days’ (053, male, age 29).   
 
Some estimated that they have used one needle to inject as many as 30 times (045, 
080) and one reported that his ‘jugular’s messed as well’ (045).  Others were less 
precise, noting that ‘we’d use ‘til they got blunt’  (004) and using blunt works was 
described as ‘reversing a double decker into your arm’  (071). 
 
Cleaning injection equipment 
 
Bleach is an extremely effective way to clean drug injection equipment and when 
used properly can inactivate the HIV found on such equipment (Shapshak et al., 
1993).  To their credit, some respondents reported that they used bleach to disinfect 
needles (008) and other injection equipment.  One respondent made specific 
reference to bleach, and the sterilising of spoons and other injection equipment 
(009). He also reported that when injecting within a group of IDUs he ‘would make 
sure it [the needle and syringe] would be clean for everyone.’  
 
A few respondents had never heard that bleach should be used to clean equipment 
(e.g., 003).  Some used other, less effective means to clean needles, e.g., cold water 
(027), vodka (003). Younger IDUs with shorter injection careers have been found to 
engage in more risk behaviours than older IDUs (Friedman et al., 1989).   A male 
respondent in the present study noted that ‘long term users would use bleach’ but as 
for less experienced injectors, he recalled that: 
 
‘Nobody had a clue.  We got no information – only from other junkies.  We 
just mimicked what we saw [other users do]’ (004, initiated heroin use at age 
25). 
 
Data collected from respondents, however, indicated that more experienced injectors 
also engage in considerable risk behaviours for infectious disease.  A respondent 
who had initiated heroin use in 1981 reported that he uses a steriliser to disinfect 
needles, but only when he prepares to inject at home (041).  Another admitted that it 
is ‘difficult’ to use bleach when he injects in the middle of the night (043, initiated 
heroin use nine years before the interview).   
 
‘Sharing’ needles and other injection equipment 
 
Koester (1994: 289) argues that the term, ‘needle sharing’ is a misnomer in that it 
suggests that the behaviour represents ‘an act of reciprocity’ based on the altruistic 
beliefs of the loaner.  In fact, he suggests, the lending and borrowing of needles is 
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influenced greatly by their lack of availability.  Nearly all of the injectors in the present 
study had at some point used another injector’s needle/syringe.  Some noted that 
they were less likely to borrow injection equipment in places where new 
needles/syringes were available, e.g., Dublin, Glasgow, and London.  The scarcity of 
new needles/syringes in Northern Ireland contributed greatly to the loaning and 
borrowing of this equipment: 
 
‘People use another’s syringe if there’s no option.  I don’t think they [health 
officials, government] understand that.  It’s the height of stupidity, to make it 
difficult to get syringes…We’ve no choice…people are driven by their desire 
to obtain’ (051, has tested positive for Hepatitis C) 
   
For some, the urgency to use heroin took precedence over a search for a new 
needle: 
 
 ‘When you’re sick enough, you’d use somebody else’s’ (041, male, age 32). 
 
Consistent with research findings reported elsewhere (McKeganey and Barnard, 
1992), the data drawn from the present study indicate that some respondents define 
‘sharing’ in terms of their relationship with the loaner/borrower.  That is, sex partners 
do not necessarily view the use of the partner’s needle as a behaviour that 
constitutes ‘sharing’ (001, 002, 003).  A female respondent reported that she has 
never ‘shared’ needles, but later in the interview she noted that she and her boyfriend 
used the same needle/syringe on every occasion that they injected together (021).  A 
female reported that she and her boyfriend always shared needles and for the most 
part she appeared to be unconcerned about loaning their equipment:  ‘It’s up to 
anyone else if they wanted to use our needle’ (035).  A male respondent reported 
that he and his girlfriend always ‘shared’ needles: 
 
‘[We were having] unprotected sex, so why not?’ (071, age 26). 
 
Others noted the distinct possibility of ‘accidental’ use of another’s needle/syringe, 
despite attempts not to do so:   
 
‘I may have accidentally shared.  I’d wake up – we’d both wake up and 
there’d be two [sets of works] on the table.  [We couldn’t recall] which one 
was whose.’ (074, male, age 43).   
 
‘At first, there’s no way that we’d share [with one another].  He set his 
here…and then after awhile we wouldn’t know whose needle was whose.’ 
(005, female) 
 
‘[At times] I can’t remember which is my own’  (073, female).   
 
A few respondents acknowledged the importance of sterile needles but appeared 
lackadaisical about ‘borrowing’ from others, even when they believed that the loaner 
was positive for HIV-antibodies.  A female respondent reported that she does not 
often use bleach but did so during the last injection episode while in the company of 
two other IDUs.  Prior to that event she had heard that one of the IDUs was HIV-
antibody positive.  She made no attempt to clean the needle during the injection 
episode, although one of the IDUs who was present did so for her (073).  
 
Another respondent described a situation in which he was in the company of two 
other injectors, both of whom were HIV-antibody positive.  The two IDUs injected first 
and the respondent recalled that he was hesitant to use the needle.  One of the other 
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IDUs showed him that they had placed plastic lining (from a carry/grocer bag) within 
the syringe and that this technique would protect the respondent when he injected 
with the same needle.  The respondent injected at that time and recalled that the 
other IDU had learned the ‘lining’ technique while incarcerated in Mountjoy Prison. 
(080). 
 
The data suggest that some respondents are unaware that other injection equipment 
(e.g., spoons, containers, water, cotton) and practises (separating drugs for use by 
two or more people) can serve as conduits for the spread of infectious diseases.  In 
fact, some researchers have suggested that these methods might be responsible for 
the high incidence of Hepatitis C among injecting drug users (Coutinho, 1998).  A 
male respondent described his most recent injection experience.  Heroin or other 
drugs were not available so he injected the MST residue from another injector’s filter: 
  
 ‘I know that person didn’t have AIDS’ (053, age 29). 
 
Similarly, respondents noted the apparent lack of knowledge among other injectors: 
 
‘People [in NI] share spoons, etc.  Hep C can live for some time on a spoon’ 
(051, age 48).   
 
 ‘They thought they’d use my water…they’re careless’ (009, age 25). 
 
Infectious Diseases 
 
The ‘sharing’ (i.e., loaning or borrowing) of needles and other injection equipment 
can involve blood-borne contact which places injection drug users at risk for 
exposure to Human Immunodeficiency Virus (HIV), Hepatitis B, and Hepatitis C 
(British Medical Association, 1997).  HIV among IDUs in New York spread very 
quickly, and during that time sterile needles for use by IDUs were not widely available 
(Des Jarlais, 1997).  It has also been noted that the rapid spread of HIV occurred in 
part because IDUs were sharing ‘with large numbers of other IDUs’ (Des Jarlais, 
1997: 90). 
 
For ethical reasons, respondents were not asked about their HIV serostatus.  The 
issue was discussed only during those few interviews when respondents raised the 
issue.   Midway into the data collection this writer was encouraged by a health 
professional to inquire about respondents’ knowledge of Hepatitis C.  In all, 20 
respondents were asked about this issue.   
 
Six persons had tested negative for Hepatitis C although the date of testing in 
relation to the injection history was not ascertained.   One of these persons recalled 
that he had never heard of the disease until he was in recovery when treatment staff 
offered to test him.  Initially, this respondent refused to be tested after his GP advised 
him:  ‘If you do [test positive for Hepatitis C] you might not get insurance.’ (006).   
  
Seven of the 20 persons confided that they were positive for the Hepatitis C virus.   
Of those who were tested in Northern Ireland, none reported having had received 
pre- and post-test counseling for Hepatitis C although some had received information 
sheets and leaflets.  One female recalled that she ‘started to feel unwell’ about six 
weeks after she had first injected a substance (cocaine).  She underwent testing at 
the time (early 1990s) and the results were returned, ‘non A and non B Hepatitis’ .  
She was tested again in 1997 and the Hepatitis C was confirmed.     
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A male respondent learned that he was positive for Hepatitis C six months after he 
had quit using heroin.  He learned of his status by observing a letter addressed to his 
GP that had been placed in his patient file.  The letter was written by staff at a 
Northern Ireland treatment facility and the content of the letter indicated that he was 
positive for Hepatitis C.  He was never notified of the infection before that time.  Nor 
did he ever receive pre- or post-test counselling for the infection. He recalled the day 
he discovered this information: 
 
‘I was crushed.  I got clean – now they’re telling me I’m going to die’ (075, 
male)  
 
Two other respondents reported that they had been tested for Hepatitis C, but did not 
share the results with the interviewer.  
 
Three persons had no knowledge at all of Hepatitis C (015, 003, 006) and a fourth 
respondent reported that he had ‘No need to be tested’ (010) because ‘ I’ve never 
used a set of works more than one time.’   Others had heard of the disease but 
lacked specific knowledge about, for example, the methods of transmission:  
 
‘I’d share [needles] with Hep C people’ (045, age 32). 
 
A female respondent (never tested) reported that her male partner (also an injector) 
tested negative for Hepatitis C and that for this reason, she would test negative as 
well (001).   
 
 Treatment and Related Support 
 
Treatment History 
 
As discussed previously, 14 persons were categorised as ‘former users,’ i.e., had 
purposely chosen to abstain from heroin and had been clean for at least two months 
prior to the interview.  Of this group, two had completed a residential or out-patient 
treatment program (004, 008).  The other 12 respondents had used various informal 
strategies that assisted them with quitting.  Six persons who had not completed 
formal treatment, had attended Narcotics Anonymous (NA) meetings on a regular 
basis.  Some attended meetings everyday for several months and then attended less 
frequently over time.  The meetings provided contact with other former users and 
friendships developed that contributed to respondents’ involvement in non-drug 
activities.  These social interactions helped to fill the void that was created when 
respondents removed themselves from the heroin lifestyle.  A few respondents 
noted, however, that Narcotics Anonymous, is  virtually non-existent in small towns 
and rural areas in Northern Ireland.    
    
Other former users reported that methadone (020,031, 035), a positive partner (032), 
the combined help from DFs, Valium and a supportive community worker (034) were 
instrumental in promoting their abstinence.  One respondent was unable to credit any 
source except sheer determination (072).   
 
Some current and former users had never had any contact at all with a drug 
treatment service.   A male respondent who initiated heroin use nine years before the 
date of the interview, reported that he had never received treatment for heroin use.   
His longest period during which he abstained from heroin lasted three to four weeks:   
 
‘I’ve done my last hit 100,000 times – I’ve cried when I’ve burned gear in the 
fire’ (042, age 25). 
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The reasons varied as to why respondents chose to avoid drug treatment.  Some 
feared that work or relationships with family would be threatened because treatment 
entry implies a semi-public acknowledgement of heroin use:   
 
‘I’d be afraid of being a marked person.  It would affect jobs, etc.’ (048, 
female). 
 
A female respondent had abstained from heroin and other drugs during the two-
month period prior to the interview.  She was hesitant to seek treatment in a 
residential setting because of concerns over the placement of her children:   
 
‘I wouldn’t put my kids anywhere.  That’s out of the question.’ (005). 
 
She was hoping to receive drug treatment as part of a ‘day release’ program but at 
the time of the interview her name still was on the waiting list for the scheme.  
Another female was in residential treatment at the time of the interview and had not 
used heroin in one month.  She stated that she avoided drug treatment for a long 
period of time: 
 
‘I thought Social Services would be at my door to take [my daughter]’ (021).   
 
The perception that parenting rights would be relinquished upon treatment entry was 
voiced by a third female respondent who described her experience upon entering a 
Northern Ireland treatment facility.  Staff there inquired about her children and she 
perceived their response to be threatening: 
 
‘They said they’d send a social worker at any time’ (001). 
 
The majority of respondents had at one time sought treatment for heroin use but 
either opted out when they inquired about the program, or left the program after they 
had been admitted.  Respondents noted that program regulations were too 
restrictive.  Some claimed, for example that a statutory agency required abstinence 
from all drugs before they could be admitted to treatment.  This regulation posed 
difficulties for respondents who were attempting to abstain from heroin but were 
using other drugs to ease withdrawal and anxiety: 
 
‘They told me to come off the benzodiazepines myself, and I’d get Britlofex’ 
(053, age 29). 
 
Another respondent was given Britlofex every day by a local agency until he tested 
positive for benzodiazepine: 
 
‘[They] took me off it.  I walked out, back on heroin, robbin’ again’ (080).   
 
Others reported that they failed to comply with treatment regulations because they 
perceived staff to have little knowledge about heroin or other drug of choice or were 
put off by sharing treatment space with alcoholics with whom they had little in 
common.  The general perception among respondents was that treatment in 
Northern Ireland focused on ‘drink, drink, drink’  (034).   
 
‘How can you get clean when there are people partying all around you?  At 
night you hear people partying.  They know alcoholics are in there.  They’re 
shouting up, “Want a drink?”  I just packed it in and went home and watched 
videos’ (009, age 25). 
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A respondent completed detoxification for heroin use on one occasion in Northern 
Ireland.  He described his interaction with a staff person:   
 
‘I had a key worker but I never went back.  I didn’t like the woman.  She 
thought I was moaning for the sake of moaning.  There were hardly any 
heroin users there before me.  I didn’t think they believed me when I told them 
how much I was using’ (074, age 43). 
 
This perception was voiced by other respondents: 
 
‘[The counsellor was] ‘a great guy but the agency was out of touch – they had 
no mechanism for dealing with junkies’ (023, male, age 34).   
 
‘They can’t relate to heroin here.  They know alcohol.  I asked them about 
drug clients and they said they don’t see too many.  I told them in a few years 
they are going to have a big massive problem’ (021, female).   
  
‘She didn’t even know what a wrap of speed was’ (047, describing her 
encounter with a staff member of a voluntary organisation that deals with 
addiction, circa 1990). 
 
Respondents reported that the choice of treatment modalities for heroin use was 
extremely limited in Northern Ireland:   
 
‘I wanted help with meditation and relaxation – it’s not available here.  I 
wanted detox here, but there’s a waiting list…I wanted it here and now’ (053, 
age 29). 
 
‘[Staff there] treat you like cattle.  Individual needs are totally different’ (009, 
age 25). 
 
[Staff name] is interested in promoting Britlofex [only]’ (027, age 26).   
 
‘GPs are terrorised by Shaftesbury Square’ (051, age 48). 
 
‘[It’s the] poorest drug service I’ve ever come across – very little discussion – 
a hurried service…a drug service should be merciful…it should have the 
quality of compassion’ (053, age 29).      
 
Services for persons with HIV or AIDS in Northern Ireland also were criticised: 
 
 ‘Agencies here cater to gay males not IDUs’ (032, positive for HIV antibodies) 
 
Interactions with GPs 
 
During the course of this study this researcher spoke with a few general practitioners 
who were quite helpful with regards to questions and issues relating to heroin use.  
Five respondents noted that they had maintained excellent and trustful relationships 
with their GPs.  Physicians are in a position to assist users but may be hindered by a 
lack of knowledge about heroin and addiction10:  
                                                           
10 One respondent reported that he had told his family dentist that he was positive for 
Hepatitis C.  In turn, the dentist contacted the respondent’s mother and told her about 
 21 
 
‘I took 60 DFs once, went to the hospital.  I told the doctor I was sick 
[withdrawal].  He wrote ‘overdose’ [on the form].  He lacked the 
understanding…wrote overdose when I had withdrawal” (008, age 25) 
 
‘You can’t smoke heroin’ Northern Ireland GP to Respondent (050). 
 
A male respondent had Hepatitis C with major symptoms.  He described his 
experience with hospital staff: 
 
‘They insisted it was withdrawal but I had gear in my pocket.  If it was 
withdrawal I would have used.  A lot of times they see a junkie and don’t look 
further’ (051, age 48).   
 
Similar to the notification system, a few respondents were hesitant to inform their GP 
about their drug use: 
 
‘Being on record…you never know who is going to see it despite what they 
say’ (048).   
 
One respondent had regretted that he had confided in his doctor: 
 
‘He asks me questions sometimes, like who I get it from…He smirks when 
you’re telling him things…puts me straight off…Every doctor in the office 
knows.  He discussed my business with the other doctors’ (034, age 31).   
 
The respondent recalled one occasion during which a second doctor in the office had 
refused to provide his prescription of Valium and DFs.  The respondent reported that 
the second doctor had told him that he ‘was on too many things’ in full hearing 
distance of other staff and patients.      
 
A second respondent also recalled somewhat judgmental behaviour on the part of his 
doctor.  Upon learning that the respondent was positive for Hepatitis C:  
 
‘She [the doctor] backed away.  She has never touched me since that day.  
Never examined me’ (075, male).    
 
Getting Clean  
 
Several respondents reported that they had purposely abstained from heroin at some 
point, although most of this group eventually relapsed.   Respondents tended to use 
their own ‘self-help’ strategies in their quest to abstain from heroin or other drugs.  A 
female respondent suggested that her children represented the real motivator to quit 
using drugs.  Just prior to quitting, she had smoked 3 ½ grams of ‘pure rock’ over a 
three-day period: 
 
‘I knew this was it for me…I didn’t want to be doing it.  I have kids’ (005).   
 
Other respondents mentioned the influence of a non-using partner: 
 
‘[She] saved my life.  She never used beyond the occasional joint.  She 
detested needles.’ (032). 
                                                                                                                                                                      
the respondent’s status.  Contact with the mother was made by the dentist without 
the consent of the respondent, an act which breaches confidentiality.       
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A male respondent recalled that he had stopped using heroin for 3 ½ years and 
without formal treatment.  His girlfriend had smoked heroin on one occasion only.  
The drug had made her ill and she never used it again.  She eventually threatened to 
leave him because of his heroin use.  He reported that this ultimatum was his 
motivator to quit (080, has since relapsed).  The female partner of another male 
respondent (020) described her feelings: 
 
‘It made me sick.  Just the thought of sticking a needle in your arm…I had 
children, I didn’t have time to go about high all day.  I gave him an ultimatum.  
The needles go or I go.  He was even ankle shooting at the time.  Two days 
later he came by and said he wanted me’.   
 
She and her IDU partner then proceeded to search the house for the needles that the 
respondent had hidden in ‘food cupboards, under the sink, under the fridge, in the 
bath, under pillows, you wouldn’t believe it.  We found every needle and broke ‘em.’ 
 
Two males reported that they had stopped using heroin when their partners became 
pregnant (009, 071).  Other positive life changes also appeared to contribute to 
cessation.  A male recalled that although several of his injecting friends had 
overdosed and died: 
 
‘It didn’t really fizz on me…Then a number of things happened in [the period 
of] one year’ (023, age 34).   
 
Within that short period of time, the respondent had learned a language, attended 
University, sought and obtained valuable employment.  Another respondent 
confirmed that his job was a primary motivator to get clean:  
 
‘[Work] it’s a protective thing…work is hard to come by’ (006, age 29).   
 
He noted also that a non-using workmate encouraged and supported him to get 
clean.  Others mentioned ‘determination’ and the opportunity for an alternative 
lifestyle: 
 
‘I hate to use the cliché but I literally woke up one morning and thought, “I 
have to get out of this lifestyle”…We had a nice flat and it was squalid.  We 
were sleeping in the living room because we couldn’t heat the other rooms.  
We’d wake up in the morning and whoever was most together would get the 
hits together.  The toilet was blocked….’ (048). 
 
In order to quit using, this respondent reported that ‘I had to get out of that 
environment to do that.’  She left the flat and stayed clean for about nine years.  She 
mentioned that it was very difficult to give up heroin without formal treatment, but 
acknowledged that, ‘I was lucky…I had somewhere else to go [to live]’ (048, 
‘dabbling’ at the time of the interview). 
 
Relapse 
 
Relapse is a common but not an absolute feature in the heroin career (Powell et al., 
1993).  Data drawn from the present study suggest that relapse into heroin use was 
associated with the continued connection to the heroin user lifestyle.  Obtaining funds 
to purchase heroin, locating suppliers, negotiating the ‘score,’ anticipating the 
withdrawal, were all considered to be important lifestyle aspects: 
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‘The whole thing’s a ritual – a social thing.  A big mission going up the road.  I 
feel it in my stomach – the anticipation.  You see each point on the motorway 
and you know you’re getting closer.  The anticipation…’  (009, age 25). 
 
‘All of their daytime activities focus on smack – you’re asking people to make 
a major change in their lives…they expect you to stop the cycle of scoring 
and getting money and do it overnight’ (053, age 29). 
 
Several years prior to the interview, another male respondent recalled that he had 
relapsed after he abstained from heroin for six months:    
  
‘I wasn’t prepared to give up the people, places, things [associated with 
heroin use]’ (008, subsequently quit using heroin again and had been clean 
for four years at the time of the interview). 
 
The data suggest that rituals surrounding needle use and injection must be 
addressed in programs that seek to treat heroin addiction through injection.  Some 
respondents, for example, have injected vodka, water, tequila, and other substances, 
‘just to inject something’ (047).  Some enjoy watching the needle ‘go in’:   
 
‘I’m addicted to needles’ (080, male, age 27).   
 
Another recalled the overwhelming sense of boredom while in a detoxification setting, 
where he often locked himself in the loo and pretended to inject: 
 
 ‘My head would even nod’ (006).   
 
Distancing one’s self from the lifestyle requires the substitution of other non-drug 
activities.  A male respondent in the present study had injected heroin for 13 years 
when he got clean the first time.  Prior to that event, he recalled that he was 
‘exhausted…I was 31 and had done nothing with my life’ (007).  At that point he 
started to attend Narcotics Anonymous (NA) meetings where he was able to observe 
and communicate with a number of people who had stopped using heroin.  He 
relapsed shortly after he had stopped attending NA meetings, an outcome that he 
believes resulted because he had ‘lost contact with abstainers.’  
 
Aftercare interventions that follow formal treatment are important for preventing 
relapse.  The limited availability of aftercare programs in Northern Ireland made it 
difficult for heroin users who were attempting to abstain:   
 
‘[There is] no support after detox except once every couple of weeks and by 
that time you are using [heroin] again’ (075, age 39). 
 
Two respondents had completed treatment in Northern Ireland, in locations far from 
their homes.  Commenting on this experience, they recalled: 
 
‘It removed me from the situation.  I was scared to return [to Belfast].  On the 
drive home I thought about heroin.  I was safe there [in treatment].  You knew 
you didn’t use there’ (008, male).       
 
‘I feel secure but I’m scared to leave – scared to go home…in case I start 
thinking about it [heroin]…I’m petrified about leaving here.  There’s no 
pressure here’ (021, female).   
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Aftercare is particularly important when users have been exposed to treatment in 
settings far removed from their home environment and away from the heroin lifestyle.  
Most of these persons return to the home environment and are faced with continuous 
reminders about heroin, yet without the security of a controlled environment.       
 
Experiences with and attitudes towards methadone 
 
Most respondents had tried methadone, although considerably fewer had taken 
methadone under the care of a physician or through a methadone program.  
Attitudes about methadone were mixed with some reporting that methadone helped 
them a great deal.  One respondent reported being clean from heroin for five weeks 
while taking methadone in the south of Ireland (015).  Methadone helped other 
respondents stay clean for three months (045), twenty months (074), two years (044, 
075).  A male respondent was taking prescribed methadone in England, but upon 
moving to Northern Ireland, the prescription was discontinued by medical staff from a 
local statutory agency.  At that time, the respondent had not used heroin in two years 
but relapsed when the prescription was refused.  Another respondent had been 
taking prescribed methadone for three years, noting that the drug ‘saved me’ (020).  
His non-using female partner confirmed that methadone had helped the respondent.  
Other respondents reported that: 
 
‘I had my best marks [at University while] on methadone’ (023, male). 
 
‘They must change the health policy here.  It’s a naïve policy based on 
negative findings about methadone’ (053, male, age 29).   
 
‘I spend millions on street drugs – it’s only £1,000 a year to keep you on 
methadone’ (044). 
 
Negative views, however, also were reported with some respondents noting that 
methadone is just as addictive as heroin (021, 046, 080).    Still others maintained 
that although they personally did not care for methadone, the drug should be 
available for other users who might benefit from it (074).   
 
Respondents also acknowledged that methadone might work best under a medically-
supervised reduction regime (053, 075) and in the short-term (051).   One male 
respondent reported that: ‘The whole junkie lifestyle is taken away’ (023) when  
persons use methadone and abstain from heroin.   
 
Notifications 
 
Thirty-three respondents were asked whether they believed that they had been 
officially registered as a ‘drug addict’ in Northern Ireland.11  Of this group, ten 
respondents indicated that they were registered as ‘addicts’ at the time of the 
interview.  Eight indicated that they had never been registered, and the remainder 
(N=15) were uncertain. Some respondents had no knowledge at all of the notification 
system and most persons were unaware that their names can be removed from the 
notification data: 
 
‘I’ve been clean for four years, but you’re forever listed [in the Addicts’ Index]’ 
(008, age 25). 
   
                                                           
11 This item was not included in the first draft of the Interview Guide but was added 
later.   
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From the interview data of the Wirral study, Parker et al. (1988: 56) briefly discussed 
the ‘myths’ that relate to the concepts of ‘notification’ and ‘registration.’  While the 
present study does not intend to distinguish between myth and fact, a number of 
respondents described their beliefs with regards to being notified as a ‘drug addict.’  
For example, one respondent indicated that his GP informed him that that medical 
authorities would alert the RUC Drug Squad if he were to be registered (023).  One 
respondent specifically requested of his doctor to not provide his/her name to the 
Register, ‘I can’t trust where that information is going’ (027).  Another reported that 
after he had completed a drug history form for a local drug service, he was dropped 
by his GP because the agency had provided his name to the Register (032).  He 
described feeling ‘tricked’ because he was registered without his consent or 
knowledge and because he never received any formal treatment.  Others expressed 
related concerns: 
 
 ‘It’s a black mark on your name.  It doesn’t help with anything’ (009, age 25).     
 
 ‘It hurts you with [trying to get] mortgages’ (044, age 30).   
 
Two persons suggested that being registered has its advantages, believing that the 
police will not ‘hassle’ or confiscate needles/syringes from registered ‘addicts’ (047, 
071).   
 
 
 26 
CONCLUSIONS AND RECOMMENDATIONS 
 
(1) Increase the availability of needles/syringes and develop methods to 
enhance the accessibility and utilisation of needle/syringe provision  
 
Official drug policies in various cultures have at times contributed to the spread of 
HIV (Wodak, 1992).  For example, in the late 1980s, laws that prohibited the 
possession of needles/syringes without prescription were not enforced in Glasgow, 
wherein the rate of HIV infection among injectors was 5 percent.  Alternatively, the 
rate of HIV was 50 percent among injectors in Edinburgh, where needle possession 
laws were rigorously enforced (Conviser and Rutledge, 1989). Citing other research, 
McKeganey and Barnard (1992) noted the possibility that HIV can spread more 
quickly when sharing occurs among large numbers of IDUs within particular groups.  
HIV among injectors spread very quickly, i.e., within two years, in Edinburgh 
(Robertson, 1994) largely because of ‘the restricted availability of injecting 
equipment’ (Gossop, 1998: 142).  Escalating HIV incidence rates within brief time 
periods also have been reported in other countries (Des Jarlais et al., 1997).  For 
example, HIV among IDUs in Manipur, North India was virtually non-existent in 1989 
but within one year the rate among IDUs had escalated to 54% (Naik et al., 1991). 
 
Research has shown that prevalence rates for injecting drug use are similar in 
Australia and the United States.  The rate of HIV among injecting drug users in the 
United States, however, is more than double the rate among Australian injectors.  
Wodak and Lurie (1996) have examined these data in greater detail and have 
concluded that HIV did not reach epidemic proportions in Australia, largely because 
of the early implementation of several harm reduction policies (e.g., methadone, 
needle exchange, education for injectors).     
 
The British Medical Association (1997: 148) has recommended that: 
 
‘Sterile injecting equipment should be comprehensively available in the NHS 
along with health advice and promotion, to reduce the spread of bloodborne 
disease and to improve general health among injecting drug users.’   
 
Research has shown that needle/syringe exchange programs have affected the HIV 
seroprevalence rate (i.e., the rate per capita of persons testing positive for HIV 
antibodies).  For example, an international survey that included several cities (most 
located within the United States) found that seroprevalence declined by 5.8% per 
year in those cities that had offered needle exchange but had increased in those 
cities that did not offer needle exchange (Hurley, 1997).  However, needle exchange 
programs must be accessible to and utilised by injectors for there to be any 
substantial decrease in risky injection practises.  Schemes that provide limited hours 
of operation (e.g., daytime hours only) might be under-utilised by injectors.   Location 
and proximity to injectors also are important.   
 
The provision of needles can be made through exchange programmes, pharmacies, 
hospitals, and street outreach.  Used alone, each of these options has its limitations, 
particularly in certain areas.  Injectors who wish to obtain needles in Ballymena, 
Bangor and other areas outside Belfast may be unwilling to obtain needles from 
chemists or needle exchange programs in these sites because of the perceived risk 
that others (customers, staff) will learn of their drug injection history.  In this scenario, 
needle provision that is visible to the public might be less likely to be utilised by 
injectors for fear of stigma and reprisal.   Street outreach or local community workers 
under the legal guise of confidentiality might represent a better source of needle 
provision in these areas.       
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The establishment of multiple sources of needle/syringe provision, however, is most 
likely to increase availability, accessibility and utilisation.  Moreover, all of these 
strategies can serve as important referral sources for other services, e.g., drug 
treatment and counselling, Narcotics Anonymous, testing for HIV and other infectious 
diseases.   
 
There is no evidence at all to suggest that increasing needle availability through 
legitimate means contributes to an increase in drug use (Des Jarlais and Friedman, 
1992).   When implemented appropriately, needle provision can lead to a reduction in 
the loaning and borrowing of needles/syringes.  Grund et al. (1992: 387) report that 
sterile needles and syringes are widely available to injectors in Rotterdam.  Absent a 
‘structural scarcity’ of needles, injectors now view sharing needles as ‘a deviant act’  
[emphasis in original]. 
 
Even when sterile needles are available, however, research has found that injectors 
often are hesitant to carry needles on their person, so as to avoid arrest (Bourgois et 
al., 1997; Maher and Dixon, 1999).  For this reason, injectors at times do not have 
needles in their possession when they are ready to use heroin (Koester, 1994), and 
this factor has been found to significantly increase the likelihood that injectors will 
share needles (Bluthenthal et al., 1999).  Similarly, police intervention practises that 
involve the confiscation and destruction of needles/syringes, also has been found to 
contribute to risky behaviours among injectors (Maher and Dixon, 1999).  These 
studies suggest the importance of resolving the often contradictory goals between 
health promotion and law enforcement.         
 
A number of IDUs in the present study initiated use in other countries, and in places 
that have (reportedly) higher rates of HIV infection among injectors than in Northern 
Ireland.  Places of initiation in the present study included Amsterdam, Dublin, 
Glasgow, Liverpool, London, and Manchester.  Moreover, regardless of place of 
initiation, several respondents had injected in other countries, and at various points in 
the heroin career.  Travel between countries among the IDU population and during 
the injection career, has been identified as a major factor in introducing the virus to 
the home country (Des Jarlais et al., 1997).   The geographic proximity of Northern 
Ireland to other high injecting areas should not be ignored.  For example, the United 
Nations International Drug Control Programme (1997: 90) has identified six ‘factors’ 
that ‘appear to facilitate the emergence of injection as a pattern of drug abuse,’ of 
which ‘geographical proximity to a country or region wherein injecting is 
commonplace’ is included. 
 
Based on the relevant research and the findings reported in this study, the 
recommendations for needle/syringe policy are as follows: 
 
• Increase the availability of free needles/syringes as quickly as possible. 
• Provide multiple sources for obtaining needles/syringes, e.g., pharmacies, 
needle exchange sites, drop-in centres, street outreach, hospitals.  
• Develop and implement periodic monitoring of the accessibility to and 
utilisation of sources of needles/syringes, to include qualtiative research 
with injectors. 
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(2) Expand and Improve Treatment and Support Services 
 
This study included a number of persons who had never been exposed to or had 
never completed formal treatment for heroin use.  Drug users who are not in contact 
with treatment or support agencies are at greater risk for disease than drug users 
who are (Grund et al., 1992).   Treatment for heroin use must be expanded, both 
conceptually and geographically in Northern Ireland.  A variety of treatment 
modalities (e.g., counsellors whose speciality area is heroin addiction, therapeutic 
communities, methadone) should be implemented as quickly as possible but based 
on careful planning, reviews of relevant research, and the use of consultants from 
other regions.  General practitioners should have the option of prescribing 
methadone, and should receive training in the area of methadone, and heroin 
addiction, generally.  The ‘Glasgow Model’ (see Gruer et al., 1997) should be 
strongly considered.      
 
Treatment modalities should include staff who are specialised in issues relating to 
heroin and injection.  Several respondents in the present study mentioned the drug 
lifestyle as being a component that must be addressed in treatment.  Some reported 
their ‘fixation’ with needles and injecting.  These issues should be addressed in any 
treatment component in which injectors partake.   
 
Methods for improving treatment entry and treatment retention in Northern Ireland 
sites must be implemented.  Treatment programs are often ideologically-based 
whereby staff view the program’s treatment philosophy as the only way forward.  This 
view fails to consider the individual needs of drug users.  A better approach would be 
to offer a range of treatment services and attempt to match the needs of the 
individual with the services available.  A co-ordinated approach whereby program 
staff liase with staff from other programs is likely to be beneficial to clients.  
 
Drug treatment services that are specifically designed for women should be 
introduced, despite the belief that their numbers are too low to justify funding for such 
programs.  Treatment programs for women might address issues relating to abuse, 
domestic violence, co-dependency, and parenting issues.  Services must include 
crèche facilities and foster an environment whereby women do not feel threatened 
that children will be placed outside their care.    
 
A number of respondents held positive attitudes about Narcotics Anonymous.  In light 
of the benefits to which respondents referred, there is a need to expand the number 
of meetings in Northern Ireland, particularly in settings outside the Greater Belfast 
area.  Also, drawing from the recent trend of some Alcoholics Anonymous programs 
(Johnson and Chappel, 1994, Kaskutas, 1994), there may also be a need to 
establish NA groups that cater to specific populations, e.g., women, gay males, etc.      
 
With regards to heroin use, general practitioners were the first point of contact for 
many of the respondents and this finding suggests the importance of the GP as an 
important source of intervention.  However, a 1987 study of British medical curricula 
noted the limitations of undergraduate training in the area of illicit drug use (Glass, 
1989) and inadequacies in substance use training still were noted nine years later 
(Crome, 1999).  This study did not examine GPs’ level and extent of knowledge 
about heroin use and its appropriate treatments.  It is recommended that this 
knowledge base be investigated, and where appropriate, that strategies be devised 
to improve the level of knowledge among GPs.     
 
Injection drug use is a major factor in the transmission of Hepatitis C (Alter and 
Moyer, 1998).  This study demonstrated that some respondents were unaware of the 
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disease or had little knowledge about prevention.  Moreover, the lack of pre- and 
post-test counseling for persons who underwent testing for Hepatitis C is of great 
concern.  Regardless of test outcome, this absence represents a missed opportunity 
to teach injectors about risk factors.  In light of the finding that some persons who 
had tested positive for Hepatitis C were still using heroin at the time of the interview, 
the importance of establishing post-test counselling is imperative and should include 
information about the physical effects of continued use of heroin and other drugs 
(including alcohol) among persons infected.               
 
Methadone 
 
Several studies have demonstrated that methadone maintenance can reduce heroin 
injection (Ward et al., 1992), criminal activity (Longshore, Hsieh and Anglin, 1994) as 
well as the rate of HIV transmission among injecting drug users (Caplehorn and 
Ross, 1995).  Although some research has disputed these findings, a meta-analysis 
that examined the effect of methadone maintenance on illegal opiate use, criminal 
activity, and risk behaviours associated with HIV, found that the treatment did indeed 
lower the rate at which these outcomes occurred (Marsch, 1998).  In particular, the 
author noted that methadone maintenance had its greatest effect on drug-related 
crime.  
 
Methadone treatment generates considerable debate among health officials and drug 
workers and the present study acknowledges this controversy.   Respondents also 
voiced diverse views on the subject.  These attitudes are important, however, for 
some respondents methadone appeared to be an effective way to reduce heroin 
consumption.   Further, there is concern that the absence of methadone provision 
can create significant health problems for users.  Pant and Soellner (1996: 15) 
described the situation in Germany in the 1980s when the professional medical 
agencies in Germany ‘refused’ to offer methadone as a treatment option to heroin 
injectors.  A number of physicians in that country who prescribed the drug faced 
prosecution, and several responded by prescribing various drugs to treat withdrawal 
among heroin-using patients.  Major problems with polydrug use began to surface, 
followed by a number of overdoses.    
 
Based on the findings reported in the present study and from the relevant literature, it 
is recommended that a methadone reduction scheme be offered in Northern Ireland.  
Appropriate implementation based on additional research and careful planning is 
crucial if heroin consumption and associated problems are to be reduced.  
Inappropriate methadone dosages and detoxification that occurs too early can result 
in fewer successes (Wodak  and Lurie, 1996).  Also, it is important to disseminate 
knowledge to methadone clients so that they can avoid health risks associated with 
methadone (e.g., polydrug use, overdose, see for example, Carolan, 1999).  Also, 
methadone might work best when combined with other support services, e.g., 
counselling, Narcotics Anonymous.       
 
(3) Develop and Implement Effective Street Outreach Initiatives   
 
IDUs in Northern Ireland represent a distinctly marginalized group which creates 
difficulties for the implementation of intervention strategies to reduce their risk 
behaviours that are associated with injection practices.  Clearly, innovative strategies 
are required, and ‘…the only possible way to reach this population is to enter its own 
territory’ (Grund et al., 1992: 338).   
 
Funded street outreach is lacking in Northern Ireland.  Street outreach represents an 
extremely effective method for assisting IDUs and can include multiple components, 
 30 
e.g., teaching IDUs about the appropriate way to clean injection equipment and the 
implications that can result from risky injection practises, distributing knowledge 
about the sources of needle provision and the ways to reduce the likelihood of 
overdose, providing referrals to drug treatment, Narcotics Anonymous, and related 
services, distributing information about testing for HIV and other infectious diseases.  
The level of knowledge of Hepatitis C and the modes for transmission, in particular, 
were strikingly low among respondents.  A good street outreach service could rectify 
this problem.       
 
It is recommended that outreach services be implemented immediately. Outreach 
components that are poorly conceived or implemented inappropriately are likely to 
fail, thus, the components of any outreach program must reflect careful planning and 
involve a thorough review of relevant research literature in this regard.   Models that 
can be used as guidelines for establishing local outreach include the Harm Reduction 
Team (Edinburgh), and the Lifeline Manchester Outreach Project (Manchester).   
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LIMITATIONS OF THE STUDY 
 
Heroin users in Northern Ireland represent a hidden population.  The sampling 
strategy (largely snowball) and data collection procedure (in-depth interviews) were 
the most appropriate methods for studying members of this subculture.  By relying on 
a non-random sample of heroin users, the extent to which the views expressed by 
respondents reflect the experiences of the population of heroin users in Northern 
Ireland is unknown.  Therefore, drawing inferences to the general population of 
heroin users in Northern Ireland is inappropriate.            
 
A second potential limitation focuses on one characteristic of the sample.  Most 
studies of heroin users have relied on treatment sites and related agencies for 
recruitment of respondents.  As a consequence, we have little information about 
heroin users who are not in contact with support services (Robson and Bruce, 1997). 
In a sense, the present study filled this void to some extent in that the majority of 
respondents had never completed a treatment program and others had no exposure 
to treatment at all.  Alternatively, the present study provides little information about 
persons who have completed drug treatment in Northern Ireland and who have 
abstained from heroin for long periods of time.   
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